ProJect Pharmaceutics has developed an innovative process for the liposomal encapsulation of API and manufacturing of drug loaded, lyophilized liposomes.
Particularly adressing processability under standard aseptic conditions, the process is cost effective and GMP compatible. In dedicated laboratories we operate a concept towards high encapsulation and low complexity of manufacturing.
Liposomal encapsulation can be used to enhance solubility, site-specific activity, and pharmacokinetics of many drug products. Our proprietary method to process drug-loaded liposomes is an innovative and straightforward way to manufacture liposomal drug products.
Liposome formulation development for the manufacturing of freeze-dried liposomes is characterized by the following features: